• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL PORTICO TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL PORTICO TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Catalog Number PRT-23
Medical Device Problem Code Perivalvular Leak (1457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/27/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on (b)(6) 2023, a 25mm portico valve was selected for an implant using a small flexnav delivery system.The sizing of the annular dimensions of the native valve was: annulus diameter 22.2mm area 381.6mm2, perimeter 69.9.The patient did not have a horizontal aorta.A pre-dilatation balloon aortic valvuloplasty (bav) performed with a non-abbott device.During the procedure, after the full deployment of portico, the physician confirmed 3 retained tabs was free and pulled back flexnav, however portico valve was moved to the ascending aorta with a final implant depth of 4mm.The patient did not have a hypertensive spike or pulmonary hypertensive episode at the time of migration.The valve moved over the annulus, the physician snared over the ostiums in order to avoid coronary occlusion.The physician aware of the ifu warning against snaring the valve.It was necessary to use a second 23mm portico valve in order to guarantee the successes of the procedure.A post-dilatation performed due to paravalvular leak (pvl) post implant of the second valve due to two points of calcium over the annulus.After 2 days, the leak was trace on echocardiogram.The patient is stable, no additional information was provided.
 
Additional Manufacturer Narrative
An event of the paravalvular leak (pvl) after implant was reported.Information from the field indicated that there were two points of calcification over the annulus that caused the pvl and that there were no deployment difficulties.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications, including specification for radial force.Based on available information, the root cause of the paravalvular leak appears to be the calcification over the annulus.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PORTICO TRANSCATHETER AORTIC VALVE
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17591280
Report Number2135147-2023-03645
Device Sequence Number2429730
Product Code NPT
UDI-Device Identifier05415067010728
UDI-Public05415067010728
Combination Product (Y/N)N
Initial Reporter CountryMX
PMA/510(K) Number
P190023
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/25/2024
Device Catalogue NumberPRT-23
Device Lot Number8945958
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/27/2023
Supplement Date Received by Manufacturer08/30/2023
Initial Report FDA Received Date08/21/2023
Supplement Report FDA Received Date09/21/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/26/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age88 YR
Patient SexMale
-
-